CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Menostar

estradiol· ingredient estradiolNatural and semisynthetic estrogens, plain· ESTRADIOL .014 mg/d; ESTRADIOL 14 ug/d
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$38.78
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other estradiol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Estradiol$0.06599−$38.71
Estradiol$0.06599−$38.71
ESTRACE$0.38605−$38.39
ABIGALE$0.69593−$38.08
Mimvey$0.70126−$38.08
DIVIGEL$1.47−$37.30
ELESTRIN$3.52−$35.26
DOTTI$7.65−$31.13

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.